Sunil Healthcare

{
  "main_header": {
    "sid": 396654,
    "name": "Sunil Healthcare",
    "stock_name": "Sunil Healthcare",
    "full_name": "Sunil Healthcare Ltd",
    "name_url": "stocks-analysis/sunil-healthcare",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "60.30",
    "chg": -2.15,
    "chgp": "-3.44%",
    "dir": -1,
    "prev_price": "62.45",
    "mcapval": "61.84 Cr",
    "mcap": "Micro Cap",
    "scripcode": 537253,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE671C01016",
    "curr_date": "Mar 24",
    "curr_time": "",
    "bse_nse_vol": "343 ",
    "exc_status": "Active",
    "traded_date": "Mar 24, 2026",
    "traded_date_str": "2026 03 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sunil-healthcare-396654-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sunil Healthcare Ltd Downgraded to Strong Sell Amid Mixed Financial and Valuation Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sunil-healthcare-ltd-downgraded-to-strong-sell-amid-mixed-financial-and-valuation-signals-3909344",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SunilHealthcare_mojoScore_3909344.png",
        "date": "2026-03-24 08:15:33",
        "description": "Sunil Healthcare Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 23 March 2026, reflecting a complex interplay of valuation improvements, financial trends, quality concerns and technical indicators. Despite some positive quarterly results and an attractive valuation profile, the company’s weak long-term fundamentals and underperformance relative to the broader market have weighed heavily on investor sentiment."
      },
      {
        "title": "Sunil Healthcare Ltd Falls to 52-Week Low of Rs.58.4 Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sunil-healthcare-ltd-falls-to-52-week-low-of-rs584-amid-market-volatility-3900515",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SunilHealthcare_priceRelatedfactors_3900515.png",
        "date": "2026-03-19 12:10:13",
        "description": "Sunil Healthcare Ltd’s stock declined sharply to a fresh 52-week low of Rs.58.4 today, marking a significant downturn amid a volatile trading session and broader market pressures. The stock’s performance contrasts with the modest recovery seen in the Sensex, underscoring sector-specific and company-level challenges."
      },
      {
        "title": "Sunil Healthcare Ltd Upgraded to Sell on Improved Valuation and Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sunil-healthcare-ltd-upgraded-to-sell-on-improved-valuation-and-financial-trends-3899811",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SunilHealthcare_mojoScore_3899811.png",
        "date": "2026-03-19 08:06:42",
        "description": "Sunil Healthcare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 18 Mar 2026, driven primarily by a marked improvement in valuation metrics and positive financial trends. Despite lingering concerns over long-term fundamentals and market underperformance, the company’s very attractive valuation and recent quarterly results have prompted a reassessment of its outlook within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Sunil Healthcare Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sunil-healthcare-ltd-valuation-shifts-signal-renewed-price-attractiveness-3899523",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SunilHealthcare_valuationdot_3899523.png",
        "date": "2026-03-19 08:00:18",
        "description": "Sunil Healthcare Ltd has seen a notable shift in its valuation parameters, moving from an attractive to a very attractive rating, despite a challenging recent performance relative to the Sensex. This change is driven by improved price-to-earnings and price-to-book value metrics, signalling potential value for investors amid a micro-cap pharmaceutical sector landscape."
      },
      {
        "title": "Sunil Healthcare Ltd Falls to 52-Week Low of Rs.58.61 Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sunil-healthcare-ltd-falls-to-52-week-low-of-rs5861-amid-continued-downtrend-3896670",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SunilHealthcare_priceRelatedfactors_3896670.png",
        "date": "2026-03-17 11:46:45",
        "description": "Sunil Healthcare Ltd’s shares declined to a fresh 52-week low of Rs.58.61 today, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical and biotechnology company’s stock has experienced sustained pressure over recent sessions, reflecting a combination of subdued financial metrics and broader market dynamics."
      },
      {
        "title": "Sunil Healthcare Ltd Stock Falls to 52-Week Low of Rs.59",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sunil-healthcare-ltd-stock-falls-to-52-week-low-of-rs59-3894127",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SunilHealthcare_priceRelatedfactors_3894127.png",
        "date": "2026-03-16 13:13:12",
        "description": "Sunil Healthcare Ltd’s shares declined sharply to a new 52-week low of Rs.59 on 16 Mar 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting persistent pressures on its valuation and market sentiment."
      },
      {
        "title": "Sunil Healthcare Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sunil-healthcare-ltd-is-rated-strong-sell-3893122",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SunilHealthcare_mojoScore_3893122.png",
        "date": "2026-03-16 10:10:47",
        "description": "Sunil Healthcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 02 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 March 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Sunil Healthcare Gains 1.52%: 4 Key Factors Driving the Week’s Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sunil-healthcare-gains-152-4-key-factors-driving-the-weeks-volatility-3891986",
        "imagepath": "",
        "date": "2026-03-15 10:01:10",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Mar:</strong> Valuation shifts signal improved price attractiveness</p>\n                    <p><strong>3 Mar:</strong> Downgrade to Strong Sell amid technical and fundamental concerns</p>\n                    <p><strong>4 Mar:</strong> Stock declines amid weak market sentiment</p>\n                    <p><strong>5 Mar:</strong> Continued price drop despite Sensex rally</p>\n                    <p><strong>6 Mar:</strong> Sharp rebound closes week positively at Rs.67.00</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.66.00</div></div>\n                    <d..."
      },
      {
        "title": "Sunil Healthcare Ltd Downgraded to Strong Sell Amid Technical and Fundamental Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sunil-healthcare-ltd-downgraded-to-strong-sell-amid-technical-and-fundamental-concerns-3865901",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SunilHealthcare_mojoScore_3865901.png",
        "date": "2026-03-03 08:19:06",
        "description": "Sunil Healthcare Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 2 March 2026, reflecting deteriorating technical indicators, modest valuation improvements, weak financial trends, and poor quality metrics. Despite some positive quarterly earnings, the company’s long-term fundamentals and technical outlook have worsened, prompting a reassessment of its investment appeal within the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 110,
    "sid": "396654",
    "stock_news_url": "https://www.marketsmojo.com/news/sunil-healthcare-396654"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "08-Feb-2026",
      "details": "Newspaper clippings regarding publication of un-audited financial results for 3rd quarter/9 months ended 31st December 2025 (both standalone and consolidated)",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Financial Results (Both Standalone And Consolidated) For The Quarter And Nine Months Ended 31.12.2025 Of FY 2025-26",
      "datetime": "06-Feb-2026",
      "details": "Board at its meeting held today interalia approved Unaudited Financial Results (both standalone and consolidated) for the quarter and nine months ended 31.12.2025 of FY 2025-26",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On 06.02.2026",
      "datetime": "06-Feb-2026",
      "details": "Pursuant to Regulation 30 of the SEBI (LODR) Regulations 2015 we are pleased to inform that the Board of Directors of the Company at their Board Meeting held on Friday February 06 2026 interalia approved Un-Audited Financial Results (standalone and consolidated) for the 3rd quarter/ nine months ended December 31 2025 of the FY 2025-26.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sunil Healthcare Ltd Downgraded to Strong Sell Amid Mixed Financial and Valuation Signals

2026-03-24 08:15:33

Sunil Healthcare Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 23 March 2026, reflecting a complex interplay of valuation improvements, financial trends, quality concerns and technical indicators. Despite some positive quarterly results and an attractive valuation profile, the company’s weak long-term fundamentals and underperformance relative to the broader market have weighed heavily on investor sentiment.

Read full news article

Sunil Healthcare Ltd Falls to 52-Week Low of Rs.58.4 Amid Market Volatility

2026-03-19 12:10:13

Sunil Healthcare Ltd’s stock declined sharply to a fresh 52-week low of Rs.58.4 today, marking a significant downturn amid a volatile trading session and broader market pressures. The stock’s performance contrasts with the modest recovery seen in the Sensex, underscoring sector-specific and company-level challenges.

Read full news article

Sunil Healthcare Ltd Upgraded to Sell on Improved Valuation and Financial Trends

2026-03-19 08:06:42

Sunil Healthcare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 18 Mar 2026, driven primarily by a marked improvement in valuation metrics and positive financial trends. Despite lingering concerns over long-term fundamentals and market underperformance, the company’s very attractive valuation and recent quarterly results have prompted a reassessment of its outlook within the Pharmaceuticals & Biotechnology sector.

Read full news article

Sunil Healthcare Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-03-19 08:00:18

Sunil Healthcare Ltd has seen a notable shift in its valuation parameters, moving from an attractive to a very attractive rating, despite a challenging recent performance relative to the Sensex. This change is driven by improved price-to-earnings and price-to-book value metrics, signalling potential value for investors amid a micro-cap pharmaceutical sector landscape.

Read full news article

Sunil Healthcare Ltd Falls to 52-Week Low of Rs.58.61 Amid Continued Downtrend

2026-03-17 11:46:45

Sunil Healthcare Ltd’s shares declined to a fresh 52-week low of Rs.58.61 today, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical and biotechnology company’s stock has experienced sustained pressure over recent sessions, reflecting a combination of subdued financial metrics and broader market dynamics.

Read full news article

Sunil Healthcare Ltd Stock Falls to 52-Week Low of Rs.59

2026-03-16 13:13:12

Sunil Healthcare Ltd’s shares declined sharply to a new 52-week low of Rs.59 on 16 Mar 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting persistent pressures on its valuation and market sentiment.

Read full news article

Sunil Healthcare Ltd is Rated Strong Sell

2026-03-16 10:10:47

Sunil Healthcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 02 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 March 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Sunil Healthcare Gains 1.52%: 4 Key Factors Driving the Week’s Volatility

2026-03-15 10:01:10

Key Events This Week

2 Mar: Valuation shifts signal improved price attractiveness

3 Mar: Downgrade to Strong Sell amid technical and fundamental concerns

4 Mar: Stock declines amid weak market sentiment

5 Mar: Continued price drop despite Sensex rally

6 Mar: Sharp rebound closes week positively at Rs.67.00

Week Open

Rs.66.00

Read full news article

Sunil Healthcare Ltd Downgraded to Strong Sell Amid Technical and Fundamental Concerns

2026-03-03 08:19:06

Sunil Healthcare Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 2 March 2026, reflecting deteriorating technical indicators, modest valuation improvements, weak financial trends, and poor quality metrics. Despite some positive quarterly earnings, the company’s long-term fundamentals and technical outlook have worsened, prompting a reassessment of its investment appeal within the Pharmaceuticals & Biotechnology sector.

Read full news article

View All News